Toll-like receptor 2 orchestrates a tumor suppressor response in non-small cell lung cancer
Fraser R. Millar(Edinburgh Royal Infirmary), Juan Carlos Acosta(Instituto de Biomedicina y Biotecnología de Cantabria), Andrea Quintanilla(Universidad de Cantabria), John Connelly(NHS Lothian), Margaret C. Frame(Edinburgh Cancer Research), Morwenna Muir(Edinburgh Cancer Research), Graeme R. Grimes(Institute of Genetics and Cancer), Andrew H. Sims(Western General Hospital), Stella Victorelli(Mayo Clinic in Florida), Simon Wilkinson(University of Edinburgh), Adam Pennycuick(University College London), Priya Hari(Edinburgh Cancer Research), Carla Salomó Coll(Edinburgh Cancer Research), Sofía Zdral(Universidad de Cantabria), Sam M. Janes(University College London), Luke Boulter(Edinburgh Cancer Research), Philippe Gautier(Institute of Genetics and Cancer), Alison Meynert(Institute of Genetics and Cancer), Vitor H. Teixeira(University College London), Elisabeth Freyer(Institute of Genetics and Cancer), João F. Passos(Newcastle University), María A. Ros(Instituto de Biomedicina y Biotecnología de Cantabria), William Wallace(University of Edinburgh)
Cited by 25
Related Papers
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
|EBioMedicine|2019|1.3k
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
|The Lancet|2013|942
Single-cell multi-omics analysis of the immune response in COVID-19
|Nature Medicine|2021|826
Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
|Cell Metabolism|2019|547